“ Tamoxifen , at oral doses ranging between … 30 mg/d, reduces tHcy levels not only in patients with advanced breast cancer,2 but also in healthy women,5 indicating that its … effect is not only due to its antitumoral activity, but also to its direct effect on estrogen-regulated targets.”
“The reduction of tHcy levels by tamoxifen (20 mg/d) was seen in women with moderate hyperhomocystinemia and in …”